United Front Against River Blindness A Nj Nonprofit Corporation

What United Front Against River Blindness A Nj Nonprofit Corporation does

United Front Against River Blindness A Nj Nonprofit Corporation (UFAR) is a U.S. 501(c)-style nonprofit corporation incorporated in New Jersey and headquartered in Princeton Junction. Founded in 2004, the organization works on neglected tropical diseases (NTDs), with a particular programmatic focus on onchocerciasis (river blindness), delivering interventions through mass drug administration (MDA) and community health programs in affected geographies. Its website (ufar-ntds.org) and stated mission position it within the global NTD elimination ecosystem alongside larger actors such as the WHO, the Carter Center, and the END Fund.

The organization's operating model is that of a small grant-funded nonprofit rather than a commercial enterprise. With 1–10 reported employees, UFAR appears to function as a lean program delivery and advocacy entity, likely relying on a narrow set of institutional donors, philanthropic foundations, and bilateral/global health funders (e.g., USAID, BMGF, DFID/FCDO, private foundations) for revenue. Its technical product is operational — community drug distribution campaigns, surveillance, and partnership-based health system support — rather than software- or IP-based. No pricing model, customer contracts, or proprietary technology assets are disclosed.

The input data is unusually thin: the firm's own website returned only a loading/verification page rather than substantive content, and no management team, board, funding rounds, audited financials, partnerships, awards, or geographic program details are available in the supplied sources. As a result, the description above reflects only what can be inferred from firmographic and mission-level metadata; concrete program metrics, geographic footprint, donor base, and financial scale are not verifiable from the provided material.

Name

United Front Against River Blindness A Nj Nonprofit Corporation

Legal name

United Front Against River Blindness A Nj Nonprofit Corporation

Website

https://ufar-ntds.org

Company type

Private

Founded year

2004

Headcount range

1–10 employees

Short description

United Front Against River Blindness is a small New Jersey–based nonprofit founded in 2004 that combats neglected tropical diseases, with a focus on river blindness, through mass drug administration and community health programs in endemic regions.

Ownership category

akta.pro rank

Product category

Neglected Tropical Disease Programs

SIC

Services-Health Services (8000)

akta.pro primary industry

Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

akta.pro secondary industries

Community Health, Prevention & Health Education (BPAGACAC), Disease-Specific Global Initiatives (HIV/TB/Malaria/NTDs) (HLAJAOAE)

Keywords

• Neglected tropical diseases
• Mass drug administration
• Community health programs
• River blindness elimination
• Global health initiatives

Headquarters

HQ city

Princeton Junction

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Core offering

United Front Against Riverblindness combats neglected tropical diseases, principally onchocerciasis (river blindness), through mass drug administration campaigns and community health programs. The nonprofit coordinates delivery of preventive chemotherapy and supports community-based disease elimination efforts in affected endemic regions.

Differentiator

Problem solved

Functional benefit

Products and services

• Mass Drug Administration for River Blindness Mass drug administration program delivering preventive chemotherapy (e.g., Mectizan/ivermectin) to at-risk communities in endemic regions to eliminate onchocerciasis (river blindness). Intended for endemic-country populations, ministries of health, and global health partners.
• Community Health Programs for NTDs Community-based health programs supporting neglected tropical disease awareness, surveillance, and intervention delivery at the last mile. Targeted at endemic communities, community health workers, and partner NGOs.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Direct peers

• RTI International: RTI International is a major implementer of USAID's NTD programs, including ENVISION and Act to End NTDs | East, directly overlapping with UFAR's MDA delivery mission.
• Sightsavers: Sightsavers is a leading international NGO that supports NTD mass drug administration programs, including onchocerciasis, across sub-Saharan Africa with a strong community-distribution model.
• The Carter Center: The Carter Center runs one of the largest onchocerciasis elimination programs globally, including mass drug administration in Africa and Latin America, making it the most direct operational peer to UFAR.
• Helen Keller International: Helen Keller International supports NTD elimination through mass drug administration and morbidity management, with overlapping program geographies and donor base.
• Children Without Worms: Children Without Worms focuses on soil-transmitted helminths, a closely adjacent NTD using community-based deworming and MDA platforms comparable to those deployed for onchocerciasis.
• END Fund: The END Fund is a private philanthropic initiative exclusively dedicated to ending the five most common NTDs, including river blindness, by funding implementing partners and coordinating MDA campaigns.

Broad incumbents

• World Health Organization (NTD Department): WHO's NTD department sets global onchocerciasis elimination policy, coordinates the Mectizan Donation Program, and provides technical guidance to all implementing NGOs including UFAR.

Others

• Mectizan Donation Program: Administered by the Task Force for Global Health, the Mectizan Donation Program is the Merck-led ivermectin donation mechanism that underpins river blindness mass drug administration worldwide.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/ufar-rdc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about United Front Against River Blindness A Nj Nonprofit Corporation